...
首页> 外文期刊>Lancet Neurology >Treatment of dystonia.
【24h】

Treatment of dystonia.

机译:肌张力障碍的治疗。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Dystonia, defined as a neurological syndrome characterised by involuntary, patterned, sustained, or repetitive muscle contractions of opposing muscles, causing twisting movements and abnormal postures, is one of the most disabling movement disorders. Although gene mutations and other causes are increasingly recognised, most patients have primary dystonia without a specific cause. Although pathogenesis-targeted treatment is still elusive, the currently available symptomatic treatment strategies are quite effective for some types of dystonia in relieving involuntary movements, correcting abnormal posture, preventing contractures, reducing pain, and improving function and quality of life. A small portion of patients have a known cause and respond to specific treatments, such as levodopa in dopa-responsive dystonia or drugs that prevent copper accumulation in Wilson's disease. Therapeutic options must be tailored to the needs of individual patients and include chemodenervation with botulinum toxin injections for patients with focal or segmental dystonia, and medical treatments or deep brain stimulation for patients with generalised dystonia.
机译:肌张力障碍是一种神经病综合征,其特征是对立的肌肉非自愿地,有图案的,持续的或重复的肌肉收缩,导致扭转运动和异常姿势,是最致残的运动障碍之一。尽管越来越多地认识到基因突变和其他原因,但大多数患者患有原发性肌张力障碍而没有特定原因。尽管针对发病机理的治疗仍然难以捉摸,但目前可用的对症治疗策略对于缓解某些类型的肌张力障碍,缓解不自主运动,纠正异常姿势,预防挛缩,减轻疼痛以及改善功能和生活质量非常有效。一小部分患者有已知病因并且对特定治疗有反应,例如多巴反应性肌张力障碍中的左旋多巴或预防威尔逊氏病中铜累积的药物。必须根据个别患者的需要量身定制治疗方案,包括对局灶性或节段性肌张力障碍患者采用肉毒杆菌毒素注射进行化学神经支配治疗,对广泛性肌张力障碍患者进行药物治疗或深部脑刺激治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号